7086-29-5

Basic information

• Product Name: 1-phenylcycloheptane-1-carboxylic acid
• Synonyms: 1-phenylcycloheptane-1-carboxylic acid;EOS-60565;1-PHENYLCYCLOHEPTANE-1-CARBOXYLIC ACID(WXG02807)
• CAS NO: 7086-29-5
• Molecular Formula: C₁₄H₁₈O₂
• Molecular Weight: 218.29152
• Mol File: 7086-29-5.mol
• Article Data: 9

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-phenylcycloheptane-1-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 1-phenylcycloheptane-1-carboxylic acid(7086-29-5)
• EPA Substance Registry System: 1-phenylcycloheptane-1-carboxylic acid(7086-29-5)

Safety Data

• Hazardous Substances Data: 7086-29-5(Hazardous Substances Data)

Usage

Molecular Structure

1-Phenylcycloheptane-1-carboxylic acid consists of a heptane ring (seven-carbon chain forming a cyclic structure) and a carboxylic acid functional group (-COOH) attached to a phenyl group (-C6H5).

Physical Properties

It is a white solid compound that is sparingly soluble in water.

Uses

The chemical is used in the synthesis of various pharmaceuticals and drug intermediates.

Biological Activities

It has been studied for its potential biological activities, such as anti-inflammatory and antimicrobial properties.

Material Development

The compound has been investigated for its potential to serve as a building block in the development of new organic materials and polymers.

Upstream product

• 1039951-10-4 1-phenylcycloheptane-1-carbonitrile 
• 7278-77-5 (1-chloro-cycloheptyl)-phenyl-methanone 
• 629-03-8 1 ,6-dibromohexane 
• 65542-30-5 7-Brom-1-phenyl-1-heptancarbonitril 
• 140-29-4 phenylacetonitrile 
• 124-38-9 carbon dioxide 
• 32621-88-8 1-methoxy-1-phenylcycloheptanol 
• 497-19-8 sodium carbonate 
• 502-42-1 cycloheptanone 
• 2082-21-5 1-phenylcycloheptanol 
• 6004-52-0 cycloheptyl(phenyl)methanone 
• 32730-85-1 cycloheptanecarbonitrile 
• 108-86-1 bromobenzene 
• 100-58-3 phenylmagnesium bromide 

Downstream Products

• 7121-65-5 1-Phenyl-1-hydroxymethyl-cycloheptan 
• 94163-02-7 methyl 1-phenylcycloheptanecarboxylate 
• 1194737-01-3 (R)-3-(1-Phenyl-cycloheptanecarbonyloxy)-1-(pyridin-2-ylcarbamoylmethyl)-1-azonia-bicyclo[2.2.2]octane chloride 
• 1194737-07-9 (R)-3-(1-Phenyl-cycloheptanecarbonyloxy)-1-(pyridin-2-ylcarbamoylmethyl)-1-azonia-bicyclo[2.2.2]octane bromide 
• 1196090-97-7 (R)-3-(1-Phenyl-cycloheptanecarbonyloxy)-1-(pyridin-4 ylcarbamoylmethyl)-1-azonia-bicyclo[2.2.2]octane chloride 
• 1194737-31-9 (R)-1-[(5-Fluoro-pyridin-2-ylcarbamoyl)-methyl]-3-(1-phenyl-cycloheptanecarbonyloxy)-1-azonia-bicyclo[2.2.2]octane chloride 
• 1196091-05-0 (R)-1-Phenylcarbamoylmethyl-3-(1-phenyl-cycloheptanecarbonyloxy)-1-azonia-bicyclo[2.2.2]octane bromide 
• 1196091-06-1 (R)-3-(1-Phenyl-cycloheptanecarbonyloxy)-1-(pyrimidin-4-ylcarbamoylmethyl)-1-azonia-bicyclo[2.2.2]octane chloride 
• 1196091-07-2 (R)-1-[(2-Fluoro-phenylcarbamoyl)-methyl]-3-(1-phenyl-cycloheptanecarbonyloxy)-1-azonia-bicyclo[2.2.2]octane bromide 
• 1196091-14-1 (R)-1-[2-(2,3-Dihydro-benzofuran-5-yl)-ethyl]-3-(1-phenyl-cycloheptanecarbonyloxy)-1-azonia-bicyclo[2.2.2]octane formate 
• 1196091-16-3 (R)-1-[2-(4-Fluoro-phenoxy)-ethyl]-3-(1-phenyl-cycloheptanecarbonyloxy)-1-azonia-bicyclo[2.2.2]octane formate 
• 1196091-23-2 (R)-1-[(5-Fluoro-pyridin-3-ylcarbamoyl)-methyl]-3-(1-phenyl-cycloheptanecarbonyloxy)-1-azonia-bicyclo[2.2.2]octane chloride 
• 1196091-34-5 (S)-1-(3-Phenoxy-propyl)-3-(1-phenyl-cycloheptanecarbonyloxy)-1-azonia-bicyclo[2.2.2]octane formate 
• 1196091-40-3 (R)-1-[(3,5-Difluoro-phenylcarbamoyl)-methyl]-3-(1-phenyl-cycloheptanecarbonyloxy)-1-azonia-bicyclo[2.2.2]octane bromide 

Relevant articles and documents

Stereospecific Construction of Contiguous Quaternary All-Carbon Centers by Oxidative Ring Contraction

Oxidative ring contraction of cyclic α-formyl ketones was facilitated by the action of H2O2under operationally simple and environmentally benign reaction conditions. The process was highly regioselective and enables stereospecific construction of contiguous quaternary all-carbon centers from stereodefined all-substituted all-cyclic ketones. The asymmetric syntheses of (+)-cuparene and (+)-tochuinyl acetate were also successively achieved by taking advantage of this novel protocol.

HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF

Provided are certain histone deacetylase (HDAC) inhibitors of Formula I, compositions thereof, and methods of their use.

QUINUCLIDINE DERIVATIVES AS MUSCARINIC M3 RECEPTOR ANTAGONISTS

The invention provides named compounds of formula (I), wherein R4 is a N-substituted quinuclidine (I) pharmaceutical compositions containing them and a process for preparing the pharmaceutical compositions. Their use in therapy for’ the treatment of conditions mediated by M3 muscarinic receptors, such as chronic obstructive pulmonary disease is also disclosed.